Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- International Breast Cancer Research Foundation
- Target Recruit Count
- 249
- Registration Number
- NCT00293540
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇧🇩Dhaka Medical College Hospital, Dhaka, Bangladesh
🇨🇳4th Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- International Breast Cancer Research Foundation
- Target Recruit Count
- 740
- Registration Number
- NCT00201851
- Locations
- 🇲🇦
National Institute of Oncology, Rabat, Morocco
🇵🇭Vicente Soto Memorial Medical Center, Cebu, Philippines
🇵🇭East Avenue Medical Center, Manila, Philippines
News
No news found